Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Non-nucleoside Reverse Transcriptase Inhibitor

Known as: NNRTI 
A substance structurally unlike a nucleoside molecule that is capable of inhibiting the function of a reverse transcriptase. These compounds do not… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2013
Review
2013
Rilpivirine is a new non-nucleoside reverse transcriptase inhibitor (NNRTI) that is approved for HIV-1 treatment-naive adult… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
Highly Cited
2011
Highly Cited
2011
BACKGROUND The non-nucleoside reverse transcriptase inhibitor (NNRTI), rilpivirine (TMC278; Tibotec Pharmaceuticals, County Cork… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Highly Cited
2009
Highly Cited
2009
Programs that monitor local, national, and regional levels of transmitted HIV-1 drug resistance inform treatment guidelines and… Expand
  • table 1
  • table 2
  • table 3
  • table 4
Highly Cited
2008
Highly Cited
2008
OBJECTIVES The aim of this study was to investigate the frequency of CYP2B6 polymorphisms (according to ethnicity) and the… Expand
  • figure 1
  • table 1
Review
2007
Review
2007
Objectives:Monitoring regional levels of transmitted HIV-1 resistance informs treatment guidelines and provides feedback on the… Expand
Highly Cited
2006
Highly Cited
2006
Objective:To compare the prevalence of resistance by adherence level in patients treated with non-nucleoside reverse… Expand
Review
2006
Review
2006
AIMS To characterize the demographic and pharmacogenetic factors that influence interpatient variability in the plasma… Expand
Highly Cited
2004
Highly Cited
2004
Anti-AIDS drug candidate and non-nucleoside reverse transcriptase inhibitor (NNRTI) TMC125-R165335 (etravirine) caused an initial… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Highly Cited
2003
Highly Cited
2003
Objective: We have shown that HIV-1 clade C variants contain a valine codon 106 polymorphism (GTG) that facilitates a V106M… Expand
Review
2002
Review
2002
OBJECTIVE New information warrants updated recommendations for the 4 central issues in antiretroviral therapy: when to start… Expand
  • table 1
  • table 2
  • table 2
  • table 3